The genome landscape of the African Green Monkey kidney-derived vero cell line

DNA Research

Volumn 21, Issue 6, 2014, Pages 673-683

  Naoki, Osada ^a   Arihiro, Kohara ^b   Toshiyuki, Yamaji ^c   Noriko, Hirayama ^b   Fumio, Kasai ^b   Suyoshi, Sekizuka ^c   Makoto, Kuroda ^c   Kentaro, Hanada ^c   Hattori, Masahira ^d  

^a NATIONAL INSTITUTE OF GENETICS   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d NONE

Author keywords

Animal cell substrate; Infectious diseases; Vaccine; Vero cell; Whole genome

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; GENOMIC DNA; INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL LINEAGE; CHLOROCEBUS SABAEUS; CHROMOSOME 12; CONTROLLED STUDY; FEMALE; GENE; GENE CLUSTER; GENE DELETION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC CODE; GENETIC TRAIT; GENETIC VARIATION; GENOME ANALYSIS; HETEROZYGOSITY LOSS; HOMOZYGOSITY; NONHUMAN; NUCLEOTIDE SEQUENCE; RETROVIRIDAE; VERO CELL LINE; ANIMAL; CHLOROCEBUS AETHIOPS; CHROMOSOME ABERRATION; GENETICS; GENOME; HUMAN; MULTIGENE FAMILY; PROVIRUS;

ANIMALS; CERCOPITHECUS AETHIOPS; CHROMOSOME ABERRATIONS; FEMALE; GENOME; HUMANS; MULTIGENE FAMILY; PROVIRUSES; RETROVIRUSES, SIMIAN; VERO CELLS;

EID: 84964313003     PISSN: 13402838     EISSN: 17561663     Source Type: Journal    
DOI: 10.1093/dnares/dsu029     Document Type: Article

References (54)

1. Yasumura, Y. and Kawakita, Y. 1963, Studies on SV40 in tissue culture: preliminary step for cancer reserach in vitro (in Japanese), Nihon Rinsho, 21, 1201-15.
2. Yasumura, Y. and Kawakita, Y. 1988, Studies on SV40 in tissue culture: preliminary step for cancer research in vitro, In: Simizu, B. and Terasima, T. (eds.), VERO cells: origin, properties and biomedical applications. Department of Microbiology School of Medicine Chiba University, Chiba, Japan, pp. 1-19.
3. Sasaki, K., Makino, S. and Kasahara, S. 1964, Studies on measles virus. II. Propagation in two established simian renal cell lines and development of a plaque assay, Kitasato Arch. Exp. Med., 37, 27-42.
4. Rhim, J.S. and Schell, K. 1967, Cytopathic and plaque assay of rubella virus in a line of African green monkey kidney cells (Vero), Proc. Soc. Exp. Biol. Med., 125, 602-6.
5. Liebhaber, H., Riordan, J.T. and Horstmann, D.M. 1967, Replication of rubella virus in a continuous line of African green monkey kidney cells (Vero), Proc. Soc. Exp. Biol. Med., 125, 636-43.
6. Simizu, B., Rhim, J.S. and Wiebenga, N.H. 1967, Characterization of the Tacaribe group of arboviruses. I. Propagation and plaque assay of Tacaribe virus in a line of African green monkey kidney cells (Vero), Proc. Soc. Exp. Biol. Med., 125, 119-23.
7. Rhim, J.S., Schell, K., Creasy, B. and Case, W. 1969, Biological characteristics and viral susceptibility of an African green monkey kidney cell line (Vero), Proc. Soc. Exp. Biol. Med., 132, 670-8.
8. Miyamura, K., Nishio, S., Ito, A., Murata, R. and Kono, R. 1974, Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. I. Studies on factors affecting the toxin and antitoxin titration, J. Biol. Stand., 2, 189-201.
9. Speirs, J.I., Stavric, S. and Konowalchuk, J. 1977, Assay of Escherichia coli heat-labile enterotoxin with vero cells, Infect. Immun., 16, 617-22.
10. Konowalchuk, J., Speirs, J.I. and Stavric, S. 1977, Vero response to a cytotoxin of Escherichia coli, Infect. Immun., 18, 775-9.
11. Remis, R.S., MacDonald, K.L., Riley, L.W., et al 1984, Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7, Ann. Intern. Med., 101, 624-6.
12. Mizusawa, H. 1988, Cell line Vero deposited to Japanese Cancer Research Resources Bank, In: Simizu, B. and Terasima, T. (eds.), VERO cells: origin, properties and biomedical applications. Department of Microbiology School of Medicine Chiba University, Chiba, Japan, pp. 24-5.
13. Earley, E.M. and Johnson, K.M. 1988, The lineage of the Vero, Vero 76 and its clone C1008 in the United States, In: Simizu, B. and Terasima, T. (eds.), VERO cells: origin, properties and biomedical applications. Department of Microbiology School of Medicine Chiba University, Chiba, Japan, pp. 26-9.
14. Ohara, H. 1988, Cytogenetic examination of VERO cells derived from the present stock, In: Simizu, B. and Terasima, T. (eds.), VERO cells: origin, properties and biomedical applications. Department of Microbiology School of Medicine Chiba University, Chiba, Japan, pp. 36-8.
15. Levenbook, I.S., Petricciani, J.C. and Elisberg, B.L. 1984, Tumorigenicity of Vero cells, J. Biol. Stand., 12, 391-8.
16. Vincent-Falquet, J.C., Peyron, L., Souvras, M., Moulin, J.C., Tektoff, J. and Patet, J. 1989, Qualification of working cell banks for the Vero cell line to produce licensed human vaccines, Dev. Biol. Stand., 70, 153-6.
17. Barrett, P.N., Mundt, W., Kistner, O. and Howard, M.K. 2009, Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines, Expert Rev. Vaccines, 8, 607-18.
18. Montomoli, E., Khadang, B., Piccirella, S., et al 2012, Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production, Expert Rev. Vaccines, 11, 587-94.
19. Horimoto, T. and Kawaoka, Y. 2006, Strategies for developing vaccines against H5N1 influenza A viruses, Trends Mol. Med., 12, 506-14.
20. Ellis, D.S., Stamford, S., Tvoey, D.G., et al 1979, Ebola and Marburg viruses: II. Their development within Vero cells and the extra-cellular formation of branched and torus forms, J. Med. Virol., 4, 213-25.
21. Zaki, A.M., van Boheemen, S., Bestebroer, T.M., Osterhaus, A.D. and Fouchier, R.A. 2012, Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia, N. Engl. J. Med., 367, 1814-20.
22. Skowronski, D.M., Janjua, N.Z., De Serres, G., et al 2014, Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses, PloS One, 9, e92153.
23. Joung, J.K. and Sander, J.D. 2013, TALENs: awidely applicable technology for targeted genome editing, Nat. Rev. Mol. Cell Biol., 14, 49-55.
24. Mali, P., Yang, L., Esvelt, K.M., et al 2013, RNA-guided human genome engineering via Cas9, Science, 339, 823-6.
25. Cong, L., Ran, F.A., Cox, D., et al 2013, Multiplex genome engineering using CRISPR/Cas systems, Science, 339, 819-23.
26. Seabright, M. 1973, Improvement of trypsin method for banding chromosomes, Lancet, 1, 1249-50.
27. Boetzer, M., Henkel, C.V., Jansen, H.J., Butler, D. and Pirovano, W. 2011, Scaffolding pre-assembled contigs using SSPACE, Bioinformatics, 27, 578-9.
28. Simpson, J.T. and Durbin, R. 2012, Efficient de novo assembly of large genomes using compressed data structures, Genome Res., 22, 549-56.
29. Stanke, M., Steinkamp, R., Waack, S. and Morgenstern, B. 2004, AUGUSTUS: aweb server for gene finding in eukaryotes, Nucleic Acids Res., 32, W309-12.
30. Li, H. and Durbin, R. 2009, Fast and accurate short read alignment with Burrows-Wheeler transform, Bioinformatics, 25, 1754-60.
31. McKenna, A., Hanna, M., Banks, E., et al 2010, The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data, Genome Res., 20, 1297-303.
32. Boeva, V., Popova, T., Bleakley, K., et al 2012, Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data, Bioinformatics, 28, 423-5.
33. Terasima, T. and Yasukawa, M. 1988, History of Vero cells in Japan, In: Simizu, B. and Terasima, T. (eds.), VERO cells: origin, properties and biomedical applications. Department of Microbiology School of Medicine Chiba University, Chiba, Japan, pp. 22-3.
34. Emeny, J.M. and Morgan, M.J. 1979, Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production, J. Gen. Virol., 43, 247-52.
35. Horaud, F. 1992, Absence of viral sequencesin the WHO-Vero Cell Bank. A collaborative study, Dev. Biol. Stand., 76, 43-6.
36. Stock, A.D. and Hsu, T.C. 1973, Evolutionary conservatism in arrangement of genetic material. A comparative analysis of chromosome banding between the rhesus macaque (2n equals 42, 84 arms) and the African green monkey (2n equals 60, 120 arms), Chromosoma, 43, 211-24.
37. Finelli, P., Stanyon, R., Plesker, R., Ferguson-Smith, M.A., O'Brien, P.C. and Wienberg, J. 1999, Reciprocal chromosome painting shows that the great difference in diploid number between human and African green monkey is mostly due to non-Robertsonian fissions, Mamm. Genome, 10, 713-8.
38. Grubb, P., Butynski, T., Oates, J., et al 2003, Assessment of the diversity of African primates, Int. J. Primatol., 24, 1301-57.
39. Haus, T., Akom, E., Agwanda, B., Hofreiter, M., Roos, C. and Zinner, D. 2013, Mitochondrial diversityand distribution of African green monkeys (Chlorocebus gray, 1870), Am. J. Primatol., 75, 350-60.
40. Wertheim, J.O. and Worobey, M. 2007, A challenge tothe ancient origin of SIVagm based on African green monkey mitochondrial genomes, PLoS Pathog., 3, e95.
41. Osada, N. and Akashi, H. 2012, Mitochondrial-nuclear interactions and accelerated compensatory evolution: evidence from the primate cytochrome C oxidase complex, Mol. Biol. Evol., 29, 337-46.
42. Raaum, R.L., Sterner, K.N., Noviello, C.M., Stewart, C.B. and Disotell, T.R. 2005, Catarrhine primate divergence dates estimated from complete mitochondrial genomes: concordance with fossil and nuclear DNA evidence, J. Hum. Evol., 48, 237-57.
43. Perelman, P., Johnson, W.E., Roos, C., et al 2011, Amolecular phylogeny of living primates, PLoS Genet., 7, e1001342.
44. GP Consortium. 2010, A map of human genome variation from population-scale sequencing, Nature, 467, 1061-73.
45. Rausch, T., Zichner, T., Schlattl, A., Stütz, A.M., Benes, V. and Korbel, J.O. 2012, DELLY: structural variant discovery by integrated paired-end and split-read analysis, Bioinformatics, 28, i333-9.
46. Victoria, J.G., Wang, C., Jones, M.S., et al 2010, Viralnucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus, J. Virol., 84, 6033-40.
47. Onions, D., Cote, C., Love, B., et al 2011, Ensuring the safety of vaccine cell substrates by massively parallel sequencing of the transcriptome, Vaccine, 29, 7117-21.
48. Desmyter, J., Melnick, J.L. and Rawls, W.E. 1968, Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero), J. Virol., 2, 955-61.
49. Diaz, M.O., Ziemin, S., Le Beau, M.M., et al. 1988, Homozygous deletion of the a-and b 1-interferon genes in human leukemia and derived cell lines, Proc. Natl. Acad. Sci. USA, 85, 5259-63.
50. Kim, W.Y. and Sharpless, N.E. 2006, The regulation of INK4/ARF in cancer and aging, Cell, 127, 265-75.
51. Popov, N. and Gil, J. 2010, Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health, Epigenetics, 5, 685-90.
52. Yang, L., Luquette, L.J., Gehlenborg, N., et al 2013, Diverse mechanisms of somatic structural variations in human cancer genomes, Cell, 153, 919-29.
53. Knezevic, I., Stacey, G., Petricciani, J. and Sheets, R. 2010, Evaluation of cell substrates for the production of biologicals: revision of WHO recommendations. Report of the WHO Study Group on Cell Substrates for the Production of Biologicals, 22-23 April 2009, Bethesda, USA, Biologicals, 38, 162-9.
54. Ma, H., Ma, Y., Ma, W., Williams, D.K., Galvin, T.A. and Khan, A.S. 2011, Chemical induction of endogenous retrovirus particles from the vero cell line of African green monkeys, J. Virol., 85, 6579-88.